Meningococcal polysaccharide diphtheria toxoid conjugate vaccine is a sterile vaccine, administered intramuscularly. It has W-135 capsular polysaccharide antigens and Neisseria meningitides serogroup A, C, Y that are separately combined to diphtheria toxoid protein.
It is prescribed to patients who are between 9 months to 55 years old to protect against meningococcal disease-causing pathogens of Neisseria meningitides strains (A, C, Y and W-135).
This drug should be administered only with your physician’s prescription. It promotes adequate antibody production and fights against disease-causing agents.